1051 Prediction of severe immune-related adverse events among real-world patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors: a SEER-medicare analysisOlajumoke A. Olateju, J. Douglas Thornton, Rajender R. Aparasu et al.|Regular and Young Investigator Award Abstracts|2025Cited by 0